the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics.
that is highly focused on medical indications which will have the largest impact, and by building a corporate headquarters that has manufacturing cleanrooms and state-of-the-art R&D laboratories, utility rooms, storage facilities and management offices.